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10th IEIDC Abstracts / Journal of Equine Veterinary Science 39 (2016) S26eS32S30foals lacking MDA, suggesting that the ﬁrst two doses of vaccine
failed to prime the immune response. Whereas six-month-old
foal from vaccinated mares did not typically show seroconversion
in response to one dose of vaccine, all mounted a measurable
response to the second dose. Based on the results of the study,
three-month-old foals from vaccinated mares may be left un-
protected if label directions for administration of a single dose as
early as 3 months of age are followed. Vaccination of foals of
rabies-vaccinated mares should be delayed until six months of
age or older and should include two doses of vaccine in the pri-
mary series, rather than the recommended one dose, in order to
consistently achieve satisfactory priming.
209
Stable enzootic transmission levels of West Nile virus in
free ranging birds from rural and urban sites in the
province of Cordoba
A.I. Quaglia, F.S. Flores, M.S. Contigiani, L.A. Diaz*
Laboratorio de Arbovirus, Instituto de Virology “Dr. J. M. Vanella”,
Facultad de Ciencias Medicas, Universidad Nacional de Cordoba,
Ciudad Universitaria X5016, Cordoba, Argentina
West Nile virus (WNV) became an important arbovirus pathogen
for equines for the American continent since its introduction in
1999. However, a worldwide emergence as an equine pathogen is
shows form last 5 years. In Argentina, ﬁrst evidence of native
circulation was registered in 2004 in birds and 2006 in equines.
With the aim to corroborate the enzootic transmission of WNV in
its potential avian hosts we survey avian sera collected in rural
(Mar Chiquita lagoon) and urban (Cordoba city) areas of Cordoba
province. Sera collections were carried out in both places during
summer and fall in 2005 and 2012 (Mar Chiquita) and in 2005 and
2013 (Cordoba). WNV seroprevalence increased between years in
Cordoba (2.6% [2005] vs. 3.3% [2013]) and Mar Chiquita (2.8
[2005] vs. 3.7 [2012]). In Cordoba city 18 bird species were
detected infected being the most seroprevalence Cattle Tyrant
(Machetornis rixosus), Rufous Hornero (Furnarius rufus) and
Creamy-bellied Thrush (Turdus amaurochalinus). On the other
hand only 9 seropositive bird species were found in Mar Chiqui-
ta.Grassland Yellow-ﬁnch (Sicalis luteola), Picui ground dove
(Columbina picui) and Rufous Hornero (Furnarius rufus) were the
most found frequently infected. Our data suggest that WNV is
actively transmitted in urban and rural areas in the central region
of the province of Cordoba, using free ranging birds as potential
amplifying hosts. The exotic West Nile virus was introduced in
Argentina in 2004. Evidences support its wide dispersion and
successful establishment in the north and central region of the
country. However, neither massive bird mortality events nor
equine and human epidemic events were reported. There is no
evidence regarding this discrepancy with the United States.
Further ecological and virological studies are needed to elucidate
factors inﬂuencing its epidemiological behavior.
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Baton Rouge, LA 70803West Nile (WNV) and Eastern Equine Encephalitis (EEE) Viruses
are endemic in the US and cause neurologic disease in horses.
Diagnosis is based on clinical signs and a serum capture ELISA IgM
titer >1:400. Vaccination of horses and foals with WNV and EEE
vaccines might illicit an IgM antibody response that could inter-
fere with the capture ELISA diagnostic test, especially if horses
and foals are tested after vaccination. The hypothesis of this study
is horses and foals vaccinated with a multivalent vaccine con-
taining WN and EEE antigens will not elicit an IgM antibody
response of >1:400. Six adult horses (8e25 years) and six 4
month old pony foals and their dams were used in the study. Both
horses and foals were vaccinated with a commercially available
combination vaccine (Vetera® Gold, Boehringer Ingelheim Vet-
medica, St. Joseph, MO) containing killed WNV and EEE antigens.
Adult horses and dams of the ponies had a yearly history of
vaccination, whereas the pony foals had not been previously
vaccinated. Blood samples were collected from the jugular vein of
the horses, dams and foals on Days 0 (prior to vaccination), 7, 14,
and 21 days after the 1st vaccination. On day 21, foals were given a
booster vaccination and additional blood samples were obtained
days 7, 14 and 21 post booster vaccination. In addition, blood
samples were obtained from the foal’s dams at the same days and
were used as sentinels for virus exposure, as foals and dams were
housed together in a pasture. Blood samples were centrifuged and
serum collected and frozen at 80C until shipment. Serologic
assays for WNV and EEE, including IgM antibody capture ELISA
(MAC-ELISA) and Plaque Reduction Neutralization Assay (PRNT),
were performed at the National Veterinary Services Laboratory
(NVSL) in Ames, IA, USA.
All MAC-ELISA titers for WNV and EEE were negative at 1:400
for the horses, foals and foal’s dams during the study period. In
the adult horses, PRNT titers ranged from 1:10 to >1:100 for EEE
and was >1:100 for WNV at all days. In the pony foals, PRNT titers
to EEE and WNV ranged from negative to 1:10 prior to vaccine
administration to >1:100 after the second vaccination. One foal
had negative PRNT titers to EEE throughout the experiment.
Vaccination with a multivalent vaccine containing WNV and EEE
elicited an antibody response in horses and pony foals. However,
vaccination did not increase IgM titers >1:400, 7 days after
vaccination in the horses or ponies and after 2nd vaccination in
naïve pony foals. Therefore, vaccination does not interfere with
serologic testing for naturally occurring WNV and EEE infections.
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West Nile virus (WNV) is a neurotropic ﬂavivirus mainly trans-
mitted throughmosquito bites and whose reservoir hosts are wild
birds. Equids and humans are incidental dead end hosts and can
develop severe neurological symptoms in 1-10% cases. Despite
enhanced reporting ofWNV outbreaks in Europe during the past 5
years, much remains to be explored about the virulence level and
determinants of WNV strains circulating in Europe. Of note,
expanding lineage 2 virus has gained a proline residue at position
249 in the non-structural 3 (NS3) protein and has caused theworst
epidemics ever experienced in central and Southern Europe
(Greece, Serbia,…). Interestingly, Brault et al. (2007) identiﬁed
NS3249P as being crucial for the virulence of WNV in American
